Key result
Despite improved glycemic control over 5 years, subclinical left ventricular dysfunction progressed in patients with type 2 diabetes, with long-axis systolic and early diastolic velocities declining by 13% and 20% (P<0.001).
Why the study?
Does improved glycemic control prevent the progression of subclinical myocardial dysfunction in patients with type 2 diabetes?
Cohort (n=27)
Does improved glycemic control prevent the progression of subclinical myocardial dysfunction in patients with type 2 diabetes?
p-value: p=<0.001
Subclinical left ventricular dysfunction progresses over 5 years in patients with type 2 diabetes despite improvements in glycemic and lipid control.
Subclinical LV dysfunction may progress in type 2 diabetes despite glycemic control; leaves open whether adjunctive therapies alter trajectory.
BACKGROUND: Patients with uncomplicated diabetes have reduced left ventricular long-axis function, related to poor glycemic control and increased conduit arterial stiffness, with increased radial function. It is unknown if improved control of risk factors can reverse these subclinical changes. PATIENTS AND METHODS: We studied 27 patients with type 2 diabetes (18 men) 57 ± 1 months (mean ± SD) after an initial visit when they were compared with healthy age- and sex-matched controls. On both visits patients had detailed echocardiographic studies including tissue Doppler, noninvasive tests of conduit arterial function, and metabolic and lipid profiling. RESULTS: Mean age at this second review was 63.4 ± 8.1 years; 48% of patients received insulin. Mean HbA1c had decreased by 13% to 8 ± 1.6% and cholesterol by 17% to 4.3 ± 1.3 mmol/L (both, P < 0.01), but long-axis systolic and early diastolic myocardial velocities had also declined, by 13% and 20%, respectively (both, P < 0.001). Body mass index had increased by 4%, arterial pulse pressure by 17% (both P < 0.01), and carotid arterial stiffness by 49% (P < 0.01). Fractional shortening (by 21%, P < 0.001), radial systolic velocity (by 13%, P < 0.05), and ejection fraction (by 9% to 68 ± 7%, P < 0.01) had all declined. Reductions in longitudinal function were best predicted by its baseline measurements, duration of diabetes, fasting triglycerides, and arterial stiffness (epsilon index). CONCLUSIONS: Despite improved diabetic control, subclinical left ventricular dysfunction progressed over 5 years. Radial compensation was reversed. Prevention of subclinical myocardial dysfunction in diabetes might require more intensive control of net cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Vintila et al. (2012) conducted a cohort in Type 2 diabetes (n=27). Type 2 diabetes over time vs. Baseline measurements was evaluated on Long-axis systolic and early diastolic myocardial velocities (p=<0.001). Despite improved glycemic control over 5 years, subclinical left ventricular dysfunction progressed in patients with type 2 diabetes, with long-axis systolic and early diastolic velocities declining by 13% and 20% (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: